Hyaluronic acid-coated and Olaparib-loaded PEI − PLGA nanoparticles for the targeted therapy of triple negative breast cancer

References

• Bayda, S., et al., 2019. The history of nanoscience and nanotechnology: from chemical-physical applications to nanomedicine. Molecules, 25 (1), 112.
   PubMed Web of Science ®Google Scholar
• Bochum, S., Berger, S., and Martens, U.M., 2018. Olaparib. Recent results in cancer research, 211, 217–233.
   PubMedGoogle Scholar
• Bundred, N., et al., 2013. Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a phase I multicentre trial in patients scheduled for elective breast cancer surgery. Investigational new drugs, 31 (4), 949–958.
   PubMed Web of Science ®Google Scholar
• Chen, J.X., et al., 2018. Fabrication of tough poly(ethylene glycol)/collagen double network hydrogels for tissue engineering. Journal of biomedical materials research. Part A, 106 (1), 192–200.
   PubMed Web of Science ®Google Scholar
• Choi, H.S., et al., 2007. Renal clearance of quantum dots. Nature biotechnology, 25 (10), 1165–1170.
   PubMed Web of Science ®Google Scholar
• Choi, K.Y., et al., 2019. Hyaluronic acid-based activatable nanomaterials for stimuli-responsive imaging and therapeutics: beyond CD44-mediated drug delivery. Advanced materials, 31 (34), 1803549.
   PubMed Web of Science ®Google Scholar
• Danhier, F., et al., 2012. PLGA-based nanoparticles: an overview of biomedical applications. Journal of controlled release, 161 (2), 505–522.
   PubMed Web of Science ®Google Scholar
• Ebrahimnejad, P., et al., 2010. Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT-29 cell lines. Nanomedicine, 6 (3), 478–485.
   PubMed Web of Science ®Google Scholar
• Eikesdal, H.P., et al., 2021. Olaparib monotherapy as primary treatment in unselected triple negative breast cancer. Annals of oncology, 32 (2), 240–249.
   PubMed Web of Science ®Google Scholar
• Farokhzad, O.C. and Langer, R., 2009. Impact of nanotechnology on drug delivery. ACS nano, 3 (1), 16–20.
   PubMed Web of Science ®Google Scholar
• Gargouri, M., et al., 2011. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles. International journal of pharmaceutics, 403 (1–2), 276–284.
   PubMed Web of Science ®Google Scholar
• Griguolo, G., et al., 2018. Olaparib for the treatment of breast cancer. Expert review of anticancer therapy, 18 (6), 519–530.
   PubMed Web of Science ®Google Scholar
• Hero, T., et al., 2019. The triple-negative breast cancer cell line MDA-MB 231 is specifically inhibited by the ionophore salinomycin. Anticancer research, 39 (6), 2821–2827.
   PubMed Web of Science ®Google Scholar
• Hu, F.Q., et al., 2009. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles. Biomaterials, 30 (36), 6955–6963.
   PubMed Web of Science ®Google Scholar
• Huang, Y.H., et al., 2018. Serum starvation-induces down-regulation of Bcl-2/Bax confers apoptosis in tongue coating-related cells in vitro. Molecular medicine reports, 17 (4), 5057–5064.
   PubMed Web of Science ®Google Scholar
• Huynh, M.M., et al., 2020. The dawn of targeted therapies for triple negative breast cancer (TNBC): a snapshot of investigational drugs in phase I and II trials. Expert opinion on investigational drugs, 29 (11), 1199–1208.
   PubMed Web of Science ®Google Scholar
• Jhan, J.R. and Andrechek, E.R., 2017. Triple-negative breast cancer and the potential for targeted therapy. Pharmacogenomics, 18 (17), 1595–1609.
   PubMed Web of Science ®Google Scholar
• Kim, K., et al., 2019. Hyaluronic acid-coated nanomedicine for targeted cancer therapy. Pharmaceutics, 555, 11–18.
   PubMed Web of Science ®Google Scholar
• Li, Y., et al., 2018. Specific cancer stem cell-therapy by albumin nanoparticles functionalized with CD44-mediated targeting. Journal of nanobiotechnology, 16 (1), 99.
   PubMed Web of Science ®Google Scholar
• Mahapatro, A. and Singh, D.K., 2011. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. Journal of nanobiotechnology, 9, 55.
   PubMed Web of Science ®Google Scholar
• Mateo, J., et al., 2016. An adaptive study to determine the optimal dose of the tablet formulation of the PARP inhibitor olaparib. Targeted oncology, 11 (3), 401–415.
   PubMed Web of Science ®Google Scholar
• Mazzucchelli, S., et al., 2017. H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer. Scientific reports, 7 (1), 7505.
   PubMed Web of Science ®Google Scholar
• Mirakabad, F.S.T., et al., 2014. PLGA-based nanoparticles as cancer drug delivery systems. Asian pacific journal of cancer prevention, 15 (2), 517–535.
   PubMedGoogle Scholar
• Pamula, E. and Menaszek, E., 2008. In vitro and in vivo degradation of poly(L: -lactide-co-glycolide) films and scaffolds. Journal of materials science. Materials in medicine, 19 (5), 2063–2070.
   PubMed Web of Science ®Google Scholar
• Peracchia, M.T., et al., 1997. PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: investigation of their drug encapsulation and release characteristics. Journal of controlled release, 46 (3), 223–231.
   Web of Science ®Google Scholar
• Perez-Garijo, A. and Steller, H., 2015. Spreading the word: non-autonomous effects of apoptosis during development, regeneration and disease. Development, 142 (19), 3253–3262.
   PubMed Web of Science ®Google Scholar
• Puglia, C. and Santonocito, D., 2019. Cosmeceuticals: nanotechnology-based strategies for the delivery of phytocompounds. Current pharmaceutical design, 25 (21), 2314–2322.
   PubMed Web of Science ®Google Scholar
• Qi, X., et al., 2015. Hyaluronic acid-grafted polyamidoamine dendrimers enable long circulation and active tumor targeting simultaneously. Carbohydrate polymers, 126, 231–239.
   PubMed Web of Science ®Google Scholar
• Soleymani, M., et al., 2020. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells. Carbohydrate polymers, 237, 116130.
   PubMed Web of Science ®Google Scholar
• Song, J.M., et al., 2019. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells. Molecular carcinogenesis, 58 (3), 321–333.
   PubMed Web of Science ®Google Scholar
• Sudha, P.N. and Rose, M.H., 2014. Beneficial effects of hyaluronic acid. Advances in food and nutrition research, 72, 137–176.
   PubMedGoogle Scholar
• Wang, K., et al., 2019. Synthesis, purification, and anticancer effect of magnetic Fe3O4-loaded poly (lactic-co-glycolic) nanoparticles of the natural drug tetrandrine. Journal of microencapsulation, 36 (4), 356–370.
   PubMed Web of Science ®Google Scholar
• Wang, S., et al., 2016. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy. Nanomedicine, 12 (2), 411–420.
   PubMed Web of Science ®Google Scholar
• Washington, C.R., Richardson, D.L., and Moore, K.N., 2019. Olaparib in the treatment of ovarian cancer. Future oncology, 15 (30), 3435–3449.
   PubMed Web of Science ®Google Scholar
• Yu, K.T., et al., 2016. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells. International journal of pharmaceutics, 497 (1–2), 78–87.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., et al., 2020. A multifunctional magnetic nanosystem based on “two strikes” effect for synergistic anticancer therapy in triple-negative breast cancer. Journal of controlled release, 322, 401–415.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., et al., 2019. Puerarin attenuates neurological deficits via Bcl-2/Bax/cleaved caspase-3 and Sirt3/SOD2 apoptotic pathways in subarachnoid hemorrhage mice. Biomedicine & pharmacotherapy, 109, 726–733.
   PubMed Web of Science ®Google Scholar
• Zhou, M., et al., 2017. Ascorbyl palmitate-incorporated paclitaxel-loaded composite nanoparticles for synergistic anti-tumoral therapy. Drug delivery, 24 (1), 1230–1242.
   PubMed Web of Science ®Google Scholar
• Zhou, Y.P. and Xie, Q.J., 2016. Hyaluronic acid-coated magnetic nanoparticles-based selective collection and detection of leukemia cells with quartz crystal microbalance. Sensors and actuators B: chemical, 223, 9–14.
   Web of Science ®Google Scholar
• Zou, Y., et al., 2019. Polyethylenimine-based nanogels for biomedical applications. Macromolecular bioscience, 19 (11), e1900272.
   PubMed Web of Science ®Google Scholar